Tilray Brands, Inc. Selling and Marketing Expense
Tilray Brands, Inc. (TLRY) reported Selling and Marketing Expense of $9.74 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2021-05-10
- Tilray Brands, Inc. selling and marketing expense for the quarter ending 2021-03-31 was $9.74M, a 46.86% decline year-over-year.
- Tilray Brands, Inc. selling and marketing expense for the quarter ending 2020-12-31 was $13.96M, a 43.38% decline year-over-year.
- Tilray Brands, Inc. selling and marketing expense for the quarter ending 2020-09-30 was $10.00M, a 41.09% decline year-over-year.
- Tilray Brands, Inc. selling and marketing expense for the quarter ending 2020-06-30 was $12.83M, a 10.67% decline year-over-year.
- Tilray Brands, Inc. selling and marketing expense for fiscal 2020 was $54.67M, a 14.33% decline from fiscal 2019.
- Tilray Brands, Inc. selling and marketing expense for fiscal 2019 was $63.81M, a 303.17% increase from fiscal 2018.
- Tilray Brands, Inc. selling and marketing expense for fiscal 2018 was $15.83M, a 120.94% increase from fiscal 2017.
- Tilray Brands, Inc. selling and marketing expense for fiscal 2017 was $7.16M, a 99.06% increase from fiscal 2016.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | $9.74M 10-Q · filed 2021-05-10 | $23.70M derived: sum of 2 quarters · filed 2021-05-10 | $33.70M derived: sum of 3 quarters · filed 2021-05-10 | $46.53M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-12-31 | $13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $23.96M derived: sum of 2 quarters · filed 2021-02-19 | $36.79M derived: sum of 3 quarters · filed 2021-02-19 | $54.67M 10-K · filed 2021-02-19 | ||
| 2020-09-30 | $10.00M 10-Q · filed 2020-11-09 | $22.83M derived: sum of 2 quarters · filed 2020-11-09 | $40.71M 10-Q · filed 2020-11-09 | $65.81M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-06-30 | $12.83M 10-Q · filed 2020-08-10 | $30.71M 10-Q · filed 2020-08-10 | $55.81M derived: sum of 3 quarters · filed 2021-05-10 | $72.78M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-03-31 | $18.33M 10-Q · filed 2021-05-10 | $17.88M 10-Q · filed 2020-05-11 | $42.98M derived: sum of 2 quarters · filed 2021-05-10 | $59.95M derived: sum of 3 quarters · filed 2021-05-10 | $74.32M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $24.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $41.63M derived: sum of 2 quarters · filed 2021-02-19 | $55.99M derived: sum of 3 quarters · filed 2021-02-19 | $63.81M 10-K · filed 2021-02-19 | $61.08M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $16.97M 10-Q · filed 2020-11-09 | $31.34M derived: sum of 2 quarters · filed 2020-11-09 | $39.16M 10-Q · filed 2020-11-09 | $45.93M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-06-30 | $14.37M 10-Q · filed 2020-08-10 | $22.19M 10-Q · filed 2020-08-10 | $28.95M derived: sum of 3 quarters · filed 2021-02-19 | $32.45M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-03-31 | $7.82M 10-Q · filed 2020-05-11 | $14.59M derived: sum of 2 quarters · filed 2021-02-19 | $18.08M derived: sum of 3 quarters · filed 2021-02-19 | $21.39M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2018-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $10.26M derived: sum of 2 quarters · filed 2021-02-19 | $13.56M derived: sum of 3 quarters · filed 2021-02-19 | $15.83M 10-K · filed 2021-02-19 | $15.37M 10-K · filed 2019-03-25 | |
| 2018-09-30 | $3.49M 10-Q · filed 2019-11-13 | $6.80M derived: sum of 2 quarters · filed 2019-11-13 | $9.06M 10-Q · filed 2019-11-13 | $12.31M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $3.31M 10-Q · filed 2019-08-13 | $5.57M 10-Q · filed 2019-08-13 | $8.82M derived: sum of 3 quarters · filed 2020-03-02 | $10.29M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $2.26M 10-Q · filed 2019-05-15 | $5.51M derived: sum of 2 quarters · filed 2020-03-02 | $6.98M derived: sum of 3 quarters · filed 2020-03-02 | $8.50M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.72M derived: sum of 2 quarters · filed 2020-03-02 | $6.24M derived: sum of 3 quarters · filed 2020-03-02 | $7.16M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $1.47M 10-Q · filed 2018-11-14 | $2.98M derived: sum of 2 quarters · filed 2018-11-14 | $3.91M 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | $1.51M 10-Q · filed 2018-08-29 | $2.44M 10-Q · filed 2018-08-29 | ||||
| 2016-12-31 | $3.60M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |